The report "Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018”, the global molecular diagnostics market will reach $7,956.9 million by 2018, growing at a CAGR of 9.7% during the forecast period (2013–2018).
Browse 92 market data Tables and 18 Figures spread through 300 Pages and in-depth TOC on “Molecular Diagnostics Market”
Early buyers will receive 10% customization on this report.
The molecular diagnostics market is segmented into five major segments, namely, application, technology, end user, product, and geography.
The global molecular diagnostics market was valued as $5.01 billion in 2013 and is poised to grow at a CAGR of 9.7% by 2018. The market is driven by rise in the infectious diseases, growing incidences of unhealthy lifestyle diseases, and increasing breast cancer cases. However, the economic crisis and unpredictable reimbursement policies will restrain the growth of this market to an extent. Reagents will be one of the most fruitful segments for the companies to invest in the near future.
The applications segment is further subdivided into infectious diseases, oncology, genetics, blood screening, microbiology, and others. Infectious diseases were the leading segment in 2013 owing to the growing population.
Get The PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=833
The technology molecular diagnostics market is subdivided into PCR, INAAT, hybridization, DNA sequencing and NGS, microarray, and others. Out of these, PCR was the leading segment while microarray is expected to be the fastest growing segment during the forecast period. This growth is due to the rise in infectious and lifestyle diseases.
The end user segment is subdivided into reference laboratories, hospitals, and others. Out of these, the reference laboratory segment accounted for the highest CAGR.
The product segment is further sub-divided into instruments, reagents, and services and software. The growth will be majorly driven due to use of reagents for molecular testing of infectious diseases.
The geographic analysis reveals that North America accounted for the largest share and is expected to grow from 2013 to 2018 at a high CAGR. In 2013, Europe accounted for the second largest share in this market; however the growth of this region will be inactive in the forecast period. Asia will be the most profitable region for the molecular diagnostic devices in the coming five years. It is poised to grow at a healthy CAGR in the forecast period.
Request for the Customization of This Report:
The key players in the molecular diagnostics market are Roche Diagnostics (Switzerland), Gen-Probe (Hologic) (U.S.), QIAGEN (Netherlands), Becton, Dickinson & Company (U.S.), Siemens Healthcare (Germany), bioMérieux (France), Abbott (U.S.), Novartis AG (Switzerland), Cepheid (U.S.), and Beckman Coulter (U.S.).
Browse Related Reports:
In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017.
Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets